Yansheng Wu

Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III–IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial

Sheng-qiang Yu, Jiandong Gao, Jing Gan, 2019, Trials.

Effects of Shizhifang on NLRP3 Inflammasome Activation and Renal Tubular Injury in Hyperuricemic Rats

Liqun He, Qiang Wan, Huiling Wang, 2017, Evidence-based complementary and alternative medicine : eCAM.

Effect and Mechanism of ShiZhiFang on Uric Acid Metabolism in Hyperuricemic Rats

Liqun He, Qiang Wan, Huiling Wang, 2018, Evidence-based complementary and alternative medicine : eCAM.

TNF-α-mediated podocyte injury via the apoptotic death receptor pathway in a mouse model of IgA nephropathy

Qiang Wan, Jiandong Gao, Yansheng Wu, 2022, Renal failure.

Huangqi Guizhi Wuwu Decoction attenuates Podocyte cytoskeletal protein damage in IgA nephropathy rats by regulating AT1R/Nephrin/c-Abl pathway.

Qiang Wan, Qiuyu Liu, Di Huang, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Hyperuricemia triggers Renal Tubular Epithelial Pyroptosis by using ROS to activate the NLRP3 inflammasome

Chuanxu Wang, Dongdong Li, Jiandong Gao, 2022, bioRxiv.

Siwu Granules and Erythropoietin Synergistically Ameliorated Anemia in Adenine-Induced Chronic Renal Failure Rats

Qiang Wan, Huiling Wang, Jiandong Gao, 2019, Evidence-based complementary and alternative medicine : eCAM.

Shizhifang ameliorates pyroptosis of renal tubular epithelial cells in hyperuricemia through inhibiting NLRP3 inflammasome.

Chuanxu Wang, Xuming Zhang, Dongdong Li, 2023, Journal of ethnopharmacology.